<DOC>
	<DOCNO>NCT00254787</DOCNO>
	<brief_summary>The purpose study compare safety tolerability IR ( Immediate-Release ) quetiapine rapid escalation scheme current approve label titration .</brief_summary>
	<brief_title>Rapid Dose Escalation Quetiapine Versus Conventional Escalation Acute Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Men woman age ≥18 ≤65 year acute schizophrenia Provision write informed consent prior enrolment Meeting criterion ( schizophrenia ) psychotic disorder full remission , concomitant organic mental disorder mental retardation Patients substance dependence Female patient pregnant , lactate risk pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>